Projects per year
Network
Projects
- 2 Active
-
Autoimmune Encephalitis - a rare and debilitating neurological illness affecting the Australian population. A study of the Australian Autoimmune Encephalitis Consortium.
Monif, M., Butzkueven, H., Reddel, S. W., Kalincik, T., Tarlinton, D., Seneviratne, U., Kulkarni, J., Buzzard, K. & Taylor, B. V. M.
1/06/20 → 31/05/25
Project: Research
-
Biomarkers to prevent disability in multiple sclerosis
Kalincik, T., Havrdova, E. K., Kuhle, J., Olsson, T., Hillert, J., Taylor, B. V. M., Malpas, C., Kilpatrick, T. J., Barnett, M. & Buzzard, K.
1/07/19 → 30/06/22
Project: Research
-
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Roos, I., Leray, E., Casey, R., Horakova, D., Havrdova, E., Izquierdo, G., Madueño, S. E., Patti, F., Edan, G., Debouverie, M., Pelletier, J., Ozakbas, S., Amato, M. P., Clavelou, P., Grammond, P., Boz, C., Buzzard, K., Skibina, O., Ciron, J., Gerlach, O. & 7 others, , 31 Aug 2021, In: Neurology. 97, 9, p. e869-e880 13 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sharmin, S., Lefort, M., Andersen, J. B., Leray, E., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand’Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C. & 66 others, , Nov 2021, In: CNS Drugs. 35, 11, p. 1217-1232 16 p.Research output: Contribution to journal › Article › Research › peer-review
-
Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium
Broadley, J., Wesselingh, R., Seneviratne, U., Kyndt, C., Beech, P., Buzzard, K., Nesbitt, C., D’Souza, W., Brodtmann, A., Kalincik, T., Butzkueven, H., O’Brien, T. J., Monif, M. & Australian Autoimmune Encephalitis Consortium, 14 Jan 2021, In: Frontiers in Immunology. 11, 10 p., 597858.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
Seery, N., Sharmin, S., Li, V., Nguyen, A-L., Meaton, C., Atvars, R., Taylor, N., Tunnell, K., Carey, J., Marriott, M. P., Buzzard, K. A., Roos, I., Dwyer, C., Baker, J., Taylor, L., Spriggs, K., Kilpatrick, T. J., Kalincik, T. & Monif, M., Aug 2021, In: CNS Drugs. 35, 8, p. 907–918 907 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis
Broadley, J., Wesselingh, R., Seneviratne, U., Kyndt, C., Beech, P., Buzzard, K., Nesbitt, C., D'souza, W., Brodtmann, A., Macdonell, R., Kalincik, T., Butzkueven, H., O'Brien, T. J., Monif, M. & on behalf of the Australian Autoimmune Encephalitis Consortium, 15 Apr 2021, In: Journal of Neuroimmunology. 353, 8 p., 577508.Research output: Contribution to journal › Article › Research › peer-review